Press release
Pharmaceutical Drug Development Sector Market Set for Explosive Growth | Catalent, Takeda Pharmaceutical, Novartis, GlaxoSmithKline
Pharmaceutical Drug Development Sector Market
Access sample report @ https://www.htfmarketreport.com/sample-report/3657872-pharmaceutical-drug-development-sector-scorecard-q3-2021-update-thematic-research
Summary
AI was one of the most dynamic technology themes for pharma in 2021, with companies forging additional strategic partnerships with AI vendors, particularly in drug development, as well as participating in funding rounds for AI start-ups. Several big pharma companies saw their AI scores increase from 4 to 5, including Bristol Myers Squibb (BMS), AstraZeneca, and Johnson and Johnson (J&J), mainly due to additional strategic partnerships and funding activity with AI vendors. BMS also announced in August 2021 that it had secured a license to an immune-modulating drug candidate created by Exscientia.
Other areas of drug development that had significant activity in 2021 include immuno-oncology and genomics, highlighting that despite the pressures that COVID-19 placed on the pharma industry, companies are still investing in innovative areas of R&D. There were several mergers and acquisitions (M&A) in immuno-oncology and genomics in 2021, including the acquisition of Five Prime Therapeutics and TeneoBio by Amgen, and Translate Bio by Sanofi.
Microbiome-related activity by big pharma has been relatively quiet in recent years, but Takeda announced in August 2021 that it was to progress a new candidate into Phase I trials in 2022. One of the most important score decreases was for Astellas in regenerative medicine, following the death of a trial participant for its gene therapy AT132. Our thematic scoring methodology is designed to identify tomorrow’s leaders rather than today’s incumbents, based on their competitive position in the 10 most important themes impacting the landscape.
Purchase Single User License of this report @ https://www.htfmarketreport.com/buy-now?format=1&report=3657872
Scope
-Drug Development Thematic Scorecard report provides a top-down, comprehensive future outlook for key players in the drug development sector over the next two to four years.
- These themes are Virtual Care, Rare Disease, Orphan Designated Drugs, Strategic Alliances, Real-world Evidence, AI, ESG, Cybersecurity, Cloud Computing, and Blockchain.
- The scorecard includes 54 companies from across the industry, including biopharmaceutical companies, biosimilar and generic manufacturers, contract development and manufacturing organizations (CDMOs), and contract research organizations (CROs).
- The methodology contains detailed information on what data sources were used to generate the thematic scores for each company.
Reasons to Buy
- Identify the key clinical trial themes for the next 2-4 years and learn how they will impact the market.
- Understand which key themes should be addressed to drive share price.
- Understand which companies are best positioned for success within critical themes and why.
- Learn which companies have underinvested in key themes and are most vulnerable to disruption.
- Help companies adapt their strategy to anticipate and benefit from these themes as they play out.
- Help identify future winners and losers in drug development to inform partnership strategies.
Companies Mentioned in the Report
Takeda Pharmaceutical Co Ltd
Merck & Co Inc
AstraZeneca Plc
Bristol-Myers Squibb Co
Pfizer Inc
Johnson & Johnson
Boehringer Ingelheim
Parexel International Corp
F. Hoffmann-La Roche Ltd
Novartis AG
GlaxoSmithKline Plc
Bayer AG
Eli Lilly and Co
IQVIA Holdings Inc
AbbVie Inc
Merck KGaA
Novo Nordisk AS
Catalent Inc
Gilead Sciences Inc
Thermo Fisher Scientific Inc
Astellas
Biogen Inc
Cipla Ltd
Lonza Group Ltd
Amgen Inc
Daiichi Sankyo Co Ltd
Vertex Pharmaceuticals Inc
WuXi AppTec Co Ltd
Charles River Laboratories International Inc
CSL Ltd
Reliance Life Sciences Pvt Ltd
Sanofi
Innovent Biologics Inc
Otsuka
Teva Pharmaceutical Industries Ltd
UCB
Dr. Reddy's Laboratories Ltd
Regeneron Pharmaceuticals Inc
Samsung Bioepis Co Ltd
Sun Pharmaceutical Industries Ltd
Biocad
Cadila Pharmaceuticals Ltd
Celltrion Inc
Coherus BioSciences Inc
CSPC Pharmaceutical Group Ltd
Generium
Intas Pharmaceuticals Ltd
Lupin Ltd
Perrigo Co Plc
Pharmaceutical Product Development LLC
Seagen Inc
Shanghai Henlius Biotech Inc
Viatris Inc
Zydus Cadila
Get Customization in the Report, Enquire Now @ https://www.htfmarketreport.com/enquiry-before-buy/3657872-pharmaceutical-drug-development-sector-scorecard-q3-2021-update-thematic-research
Table of Contents
Executive Summary
Introduction
Pharma Theme Map
Drug Development Scorecard
Company Screen
Thematic Screen
Valuation Screen
Our Thematic Research Methodology
....Continued
View Detailed Table of Content @ https://www.htfmarketreport.com/reports/3657872-pharmaceutical-drug-development-sector-scorecard-q3-2021-update-thematic-research
It's vital you keep your market knowledge up to date. If you have a different set of players/manufacturers according to geography or needs regional or country segmented reports we can provide customization accordingly.
Contact US :
Craig Francis (PR & Marketing Manager)
HTF Market Intelligence Consulting Private Limited
Unit No. 429, Parsonage Road Edison, NJ
New Jersey USA – 08837
Phone: +1 (206) 317 1218
sales@htfmarketreport.com
HTF Market Intelligence consulting is uniquely positioned empower and inspire with research and consulting services to empower businesses with growth strategies, by offering services with extraordinary depth and breadth of thought leadership, research, tools, events and experience that assist in decision making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmaceutical Drug Development Sector Market Set for Explosive Growth | Catalent, Takeda Pharmaceutical, Novartis, GlaxoSmithKline here
News-ID: 2448449 • Views: …
More Releases from HTF Market Intelligence Consulting Pvt. Ltd.
Affective Computing Market Is Booming Worldwide | Microsoft Corporation, IBM Cor …
According to HTF Market Intelligence, the Global Affective Computing market to witness a CAGR of 36.5% during the forecast period (2025-2030). The Latest Released Affective Computing Market Research assesses the future growth potential of the Affective Computing market and provides information and useful statistics on market structure and size.
This report aims to provide market intelligence and strategic insights to help decision-makers make sound investment decisions and identify potential gaps and…
LNG Filling Station Market to Get an Explosive Growth | Chevron Corporation, Exx …
According to HTF Market Intelligence, the Global LNG Filling Station market to witness a CAGR of 2.81% during the forecast period (2025-2030). The Latest Released LNG Filling Station Market Research assesses the future growth potential of the LNG Filling Station market and provides information and useful statistics on market structure and size.
This report aims to provide market intelligence and strategic insights to help decision-makers make sound investment decisions and identify…
Nanotechnology in Energy Market Is Booming Worldwide | Bruker Corporation, DuPon …
According to HTF Market Intelligence, the Global Nanotechnology in Energy market to witness a CAGR of 17.5% during the forecast period (2025-2030). The Latest Released Nanotechnology in Energy Market Research assesses the future growth potential of the Nanotechnology in Energy market and provides information and useful statistics on market structure and size.
This report aims to provide market intelligence and strategic insights to help decision-makers make sound investment decisions and identify…
Consumer Wealth Management Market Next Big Thing | Major Giants Charles Schwab, …
HTF MI recently introduced Global Consumer Wealth Management Market study with 143+ pages in-depth overview, describing about the Product / Industry Scope and elaborates market size (2025-2032). The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence.
Major Companies in Consumer Wealth Management Market are: Vanguard (US), Fidelity Investments (US), Charles Schwab (US), Morgan Stanley (US), BlackRock (US), UBS…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
